Goldman Sachs’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $467M | Sell |
2,980,168
-3,545,603
| -54% | -$532M | 0.04% | 429 |
|
|
2026
Q1 | $997M | Buy |
6,525,771
+3,780,327
| +138% | +$579M | 0.11% | 170 |
|
|
2025
Q4 | $379M | Sell |
2,745,444
-204,203
| -7% | -$26.7M | 0.05% | 391 |
|
|
2025
Q3 | $378M | Buy |
2,949,647
+407,775
| +16% | +$49.8M | 0.05% | 380 |
|
|
2025
Q2 | $308M | Sell |
2,541,872
-1,118,613
| -31% | -$126M | 0.04% | 422 |
|
|
2025
Q1 | $408M | Buy |
3,660,485
+1,377,252
| +60% | +$147M | 0.07% | 297 |
|
|
2024
Q4 | $222M | Sell |
2,283,233
-1,202,998
| -35% | -$128M | 0.04% | 465 |
|
|
2024
Q3 | $401M | Buy |
3,486,231
+405,155
| +13% | +$46M | 0.06% | 293 |
|
|
2024
Q2 | $328M | Buy |
3,081,076
+21,715
| +0.7% | +$2.18M | 0.06% | 349 |
|
|
2024
Q1 | $296M | Sell |
3,059,361
-476,541
| -13% | -$48.9M | 0.05% | 369 |
|
|
2023
Q4 | $357M | Buy |
3,535,902
+761,545
| +27% | +$73.5M | 0.07% | 308 |
|
|
2023
Q3 | $283M | Sell |
2,774,357
-123,107
| -4% | -$12.5M | 0.06% | 306 |
|
|
2023
Q2 | $292M | Sell |
2,897,464
-1,747,915
| -38% | -$175M | 0.06% | 298 |
|
|
2023
Q1 | $427M | Buy |
4,645,379
+2,768,876
| +148% | +$242M | 0.1% | 197 |
|
|
2022
Q4 | $170M | Sell |
1,876,503
-808,960
| -30% | -$68.1M | 0.04% | 477 |
|
|
2022
Q3 | $204M | Buy |
2,685,463
+50,131
| +2% | +$4.16M | 0.05% | 381 |
|
|
2022
Q2 | $223M | Sell |
2,635,332
-146,264
| -5% | -$12.8M | 0.06% | 358 |
|
|
2022
Q1 | $244M | Buy |
2,781,596
+594,194
| +27% | +$51.4M | 0.05% | 367 |
|
|
2021
Q4 | $191M | Buy |
2,187,402
+108,936
| +5% | +$9.04M | 0.04% | 476 |
|
|
2021
Q3 | $170M | Sell |
2,078,466
-208,520
| -9% | -$18.8M | 0.04% | 475 |
|
|
2021
Q2 | $209M | Sell |
2,286,986
-402,569
| -15% | -$35.8M | 0.05% | 387 |
|
|
2021
Q1 | $230M | Buy |
2,689,555
+1,060,607
| +65% | +$95.2M | 0.06% | 326 |
|
|
2020
Q4 | $154M | Sell |
1,628,948
-108,059
| -6% | -$9.44M | 0.04% | 420 |
|
|
2020
Q3 | $151M | Buy |
1,737,007
+180,323
| +12% | +$15.6M | 0.04% | 412 |
|
|
2020
Q2 | $136M | Sell |
1,556,684
-27,991
| -2% | -$2.42M | 0.04% | 443 |
|
|
2020
Q1 | $131M | Buy |
1,584,675
+168,288
| +12% | +$15M | 0.05% | 409 |
|
|
2019
Q4 | $134M | Buy |
1,416,387
+62,520
| +5% | +$5.61M | 0.03% | 556 |
|
|
2019
Q3 | $118M | Buy |
1,353,867
+85,716
| +7% | +$7.7M | 0.03% | 569 |
|
|
2019
Q2 | $116M | Sell |
1,268,151
-148,092
| -10% | -$12.5M | 0.03% | 591 |
|
|
2019
Q1 | $122M | Sell |
1,416,243
-172,510
| -11% | -$13.8M | 0.04% | 552 |
|
|
2018
Q4 | $122M | Buy |
1,588,753
+58,989
| +4% | +$4.59M | 0.04% | 524 |
|
|
2018
Q3 | $118M | Buy |
1,529,764
+189,947
| +14% | +$14M | 0.03% | 660 |
|
|
2018
Q2 | $90.7M | Buy |
1,339,817
+127,984
| +11% | +$8.83M | 0.02% | 810 |
|
|
2018
Q1 | $87.8M | Buy |
1,211,833
+121,820
| +11% | +$9.27M | 0.02% | 854 |
|
|
2017
Q4 | $82M | Buy |
1,090,013
+12,330
| +1% | +$930K | 0.02% | 930 |
|
|
2017
Q3 | $82.9M | Buy |
1,077,683
+55,734
| +5% | +$4.21M | 0.02% | 920 |
|
|
2017
Q2 | $76.4M | Sell |
1,021,949
-47,394
| -4% | -$3.36M | 0.02% | 961 |
|
|
2017
Q1 | $71.2M | Sell |
1,069,343
-71,901
| -6% | -$4.79M | 0.02% | 983 |
|
|
2016
Q4 | $74.5M | Buy |
1,141,244
+54,310
| +5% | +$3.52M | 0.02% | 984 |
|
|
2016
Q3 | $76.9M | Buy |
1,086,934
+113,940
| +12% | +$8.3M | 0.02% | 888 |
|
|
2016
Q2 | $71.9M | Sell |
972,994
-46,548
| -5% | -$3.22M | 0.02% | 865 |
|
|
2016
Q1 | $66.2M | Sell |
1,019,542
-60,232
| -6% | -$4.1M | 0.02% | 897 |
|
|
2015
Q4 | $83.2M | Buy |
1,079,774
+70,466
| +7% | +$5.6M | 0.03% | 768 |
|
|
2015
Q3 | $83.1M | Buy |
1,009,308
+117,607
| +13% | +$10.5M | 0.03% | 729 |
|
|
2015
Q2 | $78.6M | Buy |
891,701
+24,954
| +3% | +$2.29M | 0.02% | 808 |
|
|
2015
Q1 | $76.6M | Sell |
866,747
-91,329
| -10% | -$8.1M | 0.02% | 801 |
|
|
2014
Q4 | $79.5M | Buy |
958,076
+132,990
| +16% | +$11M | 0.03% | 792 |
|
|
2014
Q3 | $69.6M | Sell |
825,086
-142,406
| -15% | -$11.5M | 0.02% | 838 |
|
|
2014
Q2 | $78.5M | Sell |
967,492
-201,059
| -17% | -$15.8M | 0.02% | 807 |
|
|
2014
Q1 | $89M | Buy |
1,168,551
+387,740
| +50% | +$28.3M | 0.03% | 672 |
|
|
2013
Q4 | $56.2M | Buy |
780,811
+275,063
| +54% | +$19.1M | 0.02% | 966 |
|
|
2013
Q3 | $34.8M | Buy |
505,748
+77,792
| +18% | +$5.15M | 0.01% | 1218 |
|
|
2013
Q2 | $27.1M | Buy |
+427,956
| New | +$27.8M | 0.01% | 1308 |
|
Other funds holding NVS
Goldman Sachs's NVS Position: Q2 2026 in Review
Goldman Sachs reduced its Novartis (NVS) stake by 54% in Q2 2026, selling an estimated $532M and leaving 2,980,168 shares worth $467M. The position accounts for 0.04% of the portfolio, ranked #429.
Goldman Sachs first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $997M in Q1 2026. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Goldman Sachs held 2,980,168 shares of Novartis worth $467M as of Q2 2026.
- Goldman Sachs sold 3,545,603 Novartis shares in Q2 2026, an estimated $532M.
- Novartis made up 0.04% of Goldman Sachs's portfolio in Q2 2026, its #429 holding.
- Goldman Sachs first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Novartis position peaked at $997M in Q1 2026.
- 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.